$CRWV

CoreWeave's stock soars as earnings show major AI momentum

CoreWeave (CRWV) reported Q2 revenue of $2.58B, up from a year earlier and slightly above analysts’ $2.56B consensus, with an adjusted net loss of $567M versus $677M expected. The stock rose about 14% after hours. The company cited a scaling “inflection point,” $104B backlog, raised Q3 revenue guidance to $3.45B-$3.6B, and increased full-year guidance to $12.4B-$13.2B.

Original reporting
Published Aug 12, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 1:14 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CoreWeave's stock soars as earnings show major AI momentum — source image
Decision brief

The 30-second read

$CRWVBullishHigh
01

Why it matters

The earnings beat and raised guidance, alongside a shift toward margin expansion and sold-out near-term capacity, create a clear near-term catalyst for positioning. The key risk is execution on capacity-to-revenue conversion while funding continued buildout.

02

Market read

This is a fresh earnings and guidance catalyst for CoreWeave, with explicit revenue, margin, capex, and power buildout targets that can drive repricing.

03

What to watch

Backlog and commitments are large, but traders should monitor conversion timing into revenue and the financing mix for the $35B-$39B capex range.

Relevance 9/10Novelty 9/10Timing: after-hours Tuesday, with Q3 and full-year guidance disclosed

Background

CoreWeave is an AI cloud provider scaling data-center capacity to monetize demand from AI labs, hyperscalers, and enterprises.

Company-level read

Ticker impact

$CRWVBullishHigh confidence
Context

CoreWeave reported Q2 revenue of $2.58B, beat estimates, and guided Q3 revenue to $3.45B-$3.6B, sending shares up 14% after-hours.

Expected impact

Near-term upside bias with elevated volatility; follow-through depends on whether margin expansion and capacity monetization track guidance.

Evidence & confidence

The article discloses fresh, decision-relevant datapoints: Q2 beat, adjusted net loss better than expected, raised full-year revenue guidance, margin expansion targets, and a higher capex plan with sold-out near-term capacity.

Market effects

Reinforces demand strength for AI infrastructure and may lift sentiment across AI cloud and data-center capacity plays.

Limited direct regional read-through; impact is primarily US-listed AI infrastructure sentiment.

Supports the global AI compute buildout narrative, potentially affecting expectations for AI hardware and power infrastructure demand.

Counterpoint

The margin story depends on scaling operating leverage while capex stays very high; if monetization lags, losses could widen despite revenue growth.

Key entities

  • CoreWeave

    AI cloud provider reporting Q2 results, raised Q3 and full-year revenue guidance, and projecting margin expansion alongside higher capex.

  • Nvidia

    CoreWeave tested and ran Nvidia's next-generation Vera Rubin NVL72 platform, highlighting a strategic hardware relationship.

  • Isomorphic Labs

    Named as a notable customer add to CoreWeave’s commitments/backlog.

Related articles

$NBISMedAI 8/10

CoreWeave’s Record Q2 Supercharges Nebius Stock Ahead Of Earnings — What Does Wall Street Expect Amid Cloud Boom?

CoreWeave reported record Q2 results, with revenue up 112% to $2.58B and adjusted loss per share of $1.03, beating estimates, and raised 2026 guidance to $12.4B-$13.2B revenue and $35B-$39B capex. Nebius (NBIS) shares rose about 7% ahead of its Q2 report, with analysts expecting revenue up 446% to $574.6M and a $0.70 adjusted loss per share.

$CRWVHighAI 9/10

CoreWeave beats quarterly revenue estimates as AI cloud demand surges

Reuters reported CoreWeave beat quarterly revenue estimates and narrowed its adjusted per-share loss as AI cloud demand rose. CoreWeave posted $2.58B revenue vs $2.56B expected, adjusted loss of $1.03 vs $1.20 expected. Revenue backlog rose to $104.2B from $99.4B, with $25B+ net new commitments. Capex was $9.4B and shares rose about 10% in extended trading.